Topic55 documents tagged
Finance Signal
Biotechnology
What This Page Covers
This page collects the 55 public records POLISCOPE has tagged with “Biotechnology”. Coverage spans bills, news coverage, and campaign-finance records - each decoded into plain English and linked to its primary source. It most often overlaps with Healthcare, Pharmaceuticals, and Clinical Trials.
Active Bills
HR 5399: Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition ActThe Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition Act (HR 5399) has been introduced to the U.S. House of Representatives and referred to the Subcommittee on ConsProtecting America from Seasonal and Pandemic Influenza Act of 2026House bill creates Department of Defense Biotechnology Management Office to boost bioindustrial manufacturingNational Defense Authorization Act for Fiscal Year 2026The ACTIVATE Act: Assessing Adversary Biotechnology CapabilitiesProposed Office of Biotechnology Policy at the USDA
Recent Activity
- Mon, Sep 141 item
- Mon, Aug 311 item
- Wed, Aug 192 items
- Moderna and Merck report successful late-stage trial for personalized mRNA melanoma vaccineModerna announced that its personalized mRNA cancer vaccine, when used alongside the immunotherapy drug Keytruda, reduced the risk of melanoma recurrence or spread in a late-stage clinical trial. The
- Moderna and Merck report positive initial results for experimental mRNA cancer vaccine
- Mon, Aug 171 item
- Thu, Aug 131 item
- Wed, Aug 121 item
- Tue, Aug 111 item
Finance Signals
Finance-tagged records
1record associated with this topic
Reported financial relationships and timing signals. This does not prove motive or influence.
Key Actors
- 01San Diegolocation6 mentions
- 02Stephen Hogeperson2 mentions
- 03Modernaorganization2 mentions
- 04Mr. Fettermanperson2 mentions
- 05U.S. Food and Drug Administrationorganization2 mentions
- 06Merckorganization2 mentions
- 07Carlsbadlocation2 mentions
- 08Department of Defenseorganization2 mentions
- 09Stephane Bancelperson2 mentions
- 10Stanford Universityorganization2 mentions
Connections Preview
Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.
- Topic to billsHR 5399: Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition Act, Protecting America from Seasonal and Pandemic Influenza Act of 2026, House bill creates Department of Defense Biotechnology Management Office to boost bioindustrial manufacturing (+3 more)
- Topic to peopleStephen Hoge, Mr. Fetterman, Stephane Bancel
- Topic to orgsModerna, U.S. Food and Drug Administration, Merck (+2 more)
- Topic to financeLobbyist Registration: John Conrad (2020)
Source Trail
Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.
- Sep 14, 2026News858 Therapeutics studies potential breast and ovarian cancer treatments
- Aug 31, 2026NewsRevelation Biosciences evaluates Gemini drug candidate for kidney disease and infection treatments
- Aug 19, 2026NewsModerna and Merck report successful late-stage trial for personalized mRNA melanoma vaccine
- Aug 19, 2026NewsModerna and Merck report successful late-stage trial for personalized mRNA melanoma vaccine
- Aug 19, 2026NewsModerna and Merck report positive initial results for experimental mRNA cancer vaccine
- Aug 17, 2026NewsBlossomHill Therapeutics raises $150 million in Nasdaq initial public offering
- Aug 13, 2026NewsFDA Approvals for Gene Therapies Reach Two Dozen
- Aug 12, 2026NewsGossamer Bio prepares to submit first New Drug Application to the FDA
- Aug 11, 2026Newsn-Lorem Foundation and BioMarin Pharmaceutical partner to develop ReNU syndrome treatment
- Aug 10, 2026NewsInocras, Inc. Announces Domestic Expansion Plans in San Diego
Showing 10 of 55 source records.
